At this year’s AACR Virtual Annual Meeting, Biognosys is proud to present a minisymposium, highlighting our work with AstraZeneca and ETH Zurich on the use of a novel chemoproteomic approach to drug target identification, and three posters:
Biognosys' Presentations at the Virtual AACR Annual Conference 2021